---
title: "Weekly Recap | Marathon Petroleum -11.45%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306358577.md"
description: "Marathon Petroleum (MPC) fell 11.45% this week to close at $367.19, underperforming the S&P 500 by about 2.84 percentage points. The stock opened Monday at $410.413 and slid through the week, with the steepest drops on Tuesday and Wednesday when it briefly touched $368.77. Thursday and Friday traded in a narrow range between $363.90 and $374.558, finishing near the weekly low."
datetime: "2026-11-21T06:55:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306358577.md)
  - [en](https://longbridge.com/en/news/306358577.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306358577.md)
generator: "portal-rs"
---

# Weekly Recap | Marathon Petroleum -11.45%, most brokers rate it buy

## The Week

Marathon Petroleum (MPC) fell 11.45% this week to close at $367.19, underperforming the S&P 500 by about 2.84 percentage points. The stock opened Monday at $410.413 and slid through the week, with the steepest drops on Tuesday and Wednesday when it briefly touched $368.77. Thursday and Friday traded in a narrow range between $363.90 and $374.558, finishing near the weekly low.

## Key Events

The week’s story centred on two overlapping threads: expectations of Hormuz oil flow recovery and a North Dakota pipeline outage. Early in the week, crude prices fell on expectations that Hormuz flows would normalise, dragging US energy stocks lower, with Marathon Petroleum underperforming its peers on several days. On Thursday night, the company declared force majeure on North Dakota oil deliveries as the pipeline outage pushed local producers to move crude by truck. Around the same time, analysts flagged that MPC may be undervalued by 49% despite the dividend hike.

## Analyst Ratings

Across 18 institutions covering Marathon Petroleum, 5 rate it buy, 3 rate it overweight, 9 rate it hold, and 1 rates it underweight; none rate it sell. The consensus rating is buy, with a consensus target of $458.23529, roughly 24.8% above the week’s close of $367.19. The target range is wide, from $236 to $564, pointing to sizeable disagreement among brokers. Within the oil and gas refining and marketing industry, the stock’s rating ranks 3rd out of 17 peers covered.

## The Week Ahead

Next week brings US macro data including FHFA house prices, the Case Shiller 20-city index, consumer confidence and the Richmond Fed composite index, which could signal how macro sentiment feeds into energy positioning. Longer out, Marathon Petroleum’s FY2026 annual results are scheduled for 2 February 2027 pre-market, with consensus EPS estimates at $66.5887 and revenue at $183.5 billion.

## In Short

The week’s share-price decline coincided with falling crude prices and the North Dakota pipeline disruption. Brokers still rate the stock a consensus buy with a target above spot, and it trades around 6.84x earnings; the latest session showed large-lot inflows of about $953,506 while small and medium lots were net sellers. The key watch points are crude price direction, the pipeline restart timeline, and how macro data next week shapes sector rotation.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [MPC.US](https://longbridge.com/en/quote/MPC.US.md)

## Related News & Research

- [Marathon Petroleum declares force majeure on North Dakota oil deliveries](https://longbridge.com/en/news/306140827.md)
- [5,744 Marathon Petroleum Corporation $MPC Shares Purchased by Compass Financial Management LLC](https://longbridge.com/en/news/304414522.md)
- [Anthropic PBC (ANT) Claims Claude Solved The 167 Year Old Riemann Hypothesis](https://longbridge.com/en/news/306374461.md)
- [Is it time to buy at the bottom? Jensen Huang is still being smeared. Anthropic's IPO = a horror story.](https://longbridge.com/en/news/306347695.md)
- [Anthropic Stock—The Bull, Base And Bear Case Into Nasdaq-100 Entry](https://longbridge.com/en/news/306338240.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**